Multiple myeloma is treated by all, EXCEPT:: (A) Lenalidomide, (B) Boezomib, (C) Thalidomide, (D) All of the above
Answer is D. Relapsed myeloma can be treated with novel agents including lenalidomide and/or boezomib. Thalidomide, if not used as initial therapy, can achieve responses in refractory cases. High-dose melphalan and stem cell transplant, if not used earlier, also have activity in patients with refractory disease. Ref: Harrison's principle of internal medicine 17th edition, chapter 106.